Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2013 3
2014 13
2015 4
2016 1
2017 5
2018 8
2019 13
2020 6
2021 9
2022 12
2023 4
2024 6

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

79 results

Results by year

Filters applied: . Clear all
Page 1
Correction to: Tocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trial.
Perrone F, Piccirillo MC, Ascierto PA, Salvarani C, Parrella R, Marata AM, Popoli P, Ferraris L, Marrocco-Trischitta MM, Ripamonti D, Binda F, Bonfanti P, Squillace N, Castelli F, Muiesan ML, Lichtner M, Calzetti C, Salerno ND, Atripaldi L, Cascella M, Costantini M, Dolci G, Facciolongo NC, Fraganza F, Massari M, Montesarchio V, Mussini C, Negri EA, Botti G, Cardone C, Gargiulo P, Gravina A, Schettino C, Arenare L, Chiodini P, Gallo C; TOCIVID-19 investigators, Italy. Perrone F, et al. J Transl Med. 2021 Oct 21;19(1):442. doi: 10.1186/s12967-021-03094-9. J Transl Med. 2021. PMID: 34674735 Free PMC article. No abstract available.
Tocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trial.
Perrone F, Piccirillo MC, Ascierto PA, Salvarani C, Parrella R, Marata AM, Popoli P, Ferraris L, Marrocco-Trischitta MM, Ripamonti D, Binda F, Bonfanti P, Squillace N, Castelli F, Muiesan ML, Lichtner M, Calzetti C, Salerno ND, Atripaldi L, Cascella M, Costantini M, Dolci G, Facciolongo NC, Fraganza F, Massari M, Montesarchio V, Mussini C, Negri EA, Botti G, Cardone C, Gargiulo P, Gravina A, Schettino C, Arenare L, Chiodini P, Gallo C; TOCIVID-19 investigators, Italy. Perrone F, et al. J Transl Med. 2020 Oct 21;18(1):405. doi: 10.1186/s12967-020-02573-9. J Transl Med. 2020. PMID: 33087150 Free PMC article. Clinical Trial.
Beclabuvir for the treatment of hepatitis C.
Gentile I, Zappulo E, Buonomo AR, Maraolo AE, Borgia G. Gentile I, et al. Among authors: zappulo e. Expert Opin Investig Drugs. 2015;24(8):1111-21. doi: 10.1517/13543784.2015.1059820. Epub 2015 Jul 9. Expert Opin Investig Drugs. 2015. PMID: 26156630 Review.
Diabetes and COVID-19: The potential role of mTOR.
Pinchera B, Scotto R, Buonomo AR, Zappulo E, Stagnaro F, Gallicchio A, Viceconte G, Sardanelli A, Mercinelli S, Villari R, Foggia M, Gentile I; Federico II COVID Team. Pinchera B, et al. Among authors: zappulo e. Diabetes Res Clin Pract. 2022 Apr;186:109813. doi: 10.1016/j.diabres.2022.109813. Epub 2022 Mar 3. Diabetes Res Clin Pract. 2022. PMID: 35248653 Free PMC article. Review.
Management of chronic viral hepatitis in the hematological patient.
Nicolini LA, Zappulo E, Viscoli C, Mikulska M. Nicolini LA, et al. Among authors: zappulo e. Expert Rev Anti Infect Ther. 2018 Mar;16(3):227-241. doi: 10.1080/14787210.2018.1438264. Epub 2018 Feb 18. Expert Rev Anti Infect Ther. 2018. PMID: 29415584 Review.
79 results